A landscape of patient-derived cancer-associated fibroblast signals in endometrial cancers.

CAF markers endometrial cancers patient-specific CAF primary culture

Journal

American journal of cancer research
ISSN: 2156-6976
Titre abrégé: Am J Cancer Res
Pays: United States
ID NLM: 101549944

Informations de publication

Date de publication:
2024
Historique:
received: 09 09 2023
accepted: 02 11 2023
medline: 8 3 2024
pubmed: 8 3 2024
entrez: 8 3 2024
Statut: epublish

Résumé

In conversation with endometrial tumor cells, the endometrial cancer-associated fibroblasts (CAFs) are the "partners in crime" of uterine neoplasm's highly heterogeneous tumor microenvironment (TME). We designed a laboratory-friendly method to culture endometrial CAFs on a patient-to-patient basis for studying the CAF-TME and CAF-tumor cell interaction(s). Here, we present a comprehensive characterization of endometrial CAFs derived from patients' tumor tissues (T) and tumor-adjacent normal tissues (N). We used more than 80 T and N from 53 consecutive consented patients with endometrial cancers at the Avera Cancer Institute. We derived TCAF and NCAF in a non-enzymatic feeder-layer culture and characterized their expression of markers by qRT-PCR, flow cytometry, immunocytochemistry, immunofluorescence, and Western blot. Although similar in the expression pattern of EpCAM-/CK18-/vimentin+ as in ovarian CAFs, endometrial NCAFs, and TCAFs characteristically presented dual morphology in culture. Endometrial CAFs were EpCAM-/CK18-/CD45-/CD31-/SMA+/TE-7+/PDGFRA+/CXCL12+/Meflin+/CD155+/CD90+ with patient-specific positivity for S100A4/FAP/PD-L1/CD44. Endometrial CAFs expressed mRNAs for signaling proteins of several pathways and receptor-ligands, including (1) cell cycle pathway, (2) TGF pathway, (3) FGF pathway, (4) Wnt-beta-catenin pathway, (5) HER pathway, (6) tyrosine kinase receptor ligands, and (7) steroid receptors. We tested the hypoxic response of CAFs to show that endometrial CAFs upregulate MMP1 in a HIF-1a-independent manner. In trying to delineate the relationship between expressions of CAF markers and T-cells in the tumor tissue, we observed that FAP-positive CAFs that are derived from CD4/CD8 positive tumor tissue expressed CXCL12 mRNA. The data indicate the role of the CXCL12-CXCR4 pathway of the CAF-rich stroma in the lymphocytic infiltration of the tumor. We demonstrate that endometrial CAFs can be cultured in an enzymatic-digestion-independent manner, and their signaling landscape can be mapped toward understanding CAF-TME dialogue. Our data will help unearth the functional relevance of endometrial CAFs in the context of clinical outcomes and designing CAF-inclusive therapy in the future.

Identifiants

pubmed: 38455423
pmc: PMC10915338

Types de publication

Journal Article

Langues

eng

Pagination

467-489

Informations de copyright

AJCR Copyright © 2024.

Déclaration de conflit d'intérêts

None.

Auteurs

Raed Sulaiman (R)

Department of Pathology, Avera Cancer Institute Sioux Falls, SD 57108, USA.

Nischal Koirala (N)

Translational Oncology Laboratory, Avera Cancer Institute Sioux Falls, SD 57108, USA.
Comprehensive Cancer Center, The Ohio State University Wexner Medical Center Columbus, OH 43210, USA.

Jennifer C Aske (JC)

Translational Oncology Laboratory, Avera Cancer Institute Sioux Falls, SD 57108, USA.

Xiaoqian Lin (X)

Translational Oncology Laboratory, Avera Cancer Institute Sioux Falls, SD 57108, USA.

Luis Rojas-Espaillat (L)

Department of Gynecologic Oncology, Avera Cancer Institute Sioux Falls, SD 57108, USA.

David Starks (D)

Department of Gynecologic Oncology, Avera Cancer Institute Sioux Falls, SD 57108, USA.

Adam Dale (A)

Translational Oncology Laboratory, Avera Cancer Institute Sioux Falls, SD 57108, USA.

Kris Gaster (K)

Assistant VP Outpatient Cancer Clinics, Avera Cancer Institute Sioux Falls, SD 57108, USA.

Pradip De (P)

Translational Oncology Laboratory, Avera Cancer Institute Sioux Falls, SD 57108, USA.
Department of Internal Medicine, University of South Dakota SSOM Sioux Falls, SD 57108, USA.
VieCure Greenwood Village, CO 80111, USA.

Nandini Dey (N)

Translational Oncology Laboratory, Avera Cancer Institute Sioux Falls, SD 57108, USA.

Classifications MeSH